Dow Down0.62% Nasdaq Down1.14%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
77.40 0.37(0.48%) Sep 22, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.63-0.65-4.99-2.74
No. of Analysts6.006.007.008.00
Low Estimate-0.71-0.72-5.63-3.27
High Estimate-0.55-0.55-2.69-2.01
Year Ago EPS-0.48-0.51-1.45-4.99
Revenue EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate8.94M8.94M33.57M45.90M
No. of Analysts6688
Low Estimate7.20M7.20M30.00M20.00M
High Estimate11.00M11.00M37.60M106.30M
Year Ago Sales8.99M10.85M47.17M33.57M
Sales Growth (year/est)-0.60%-17.60%-28.80%36.70%
Earnings HistorySep 13Dec 13Mar 14Jun 14
EPS Est-0.39-0.45-0.54-0.55
EPS Actual-0.48-0.51-3.70-0.58
Difference-0.09-0.06-3.16-0.03
Surprise %-23.10%-13.30%-585.20%-5.50%
EPS TrendsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.63-0.65-4.99-2.74
7 Days Ago-0.62-0.64-4.92-2.67
30 Days Ago-0.62-0.64-5.37-2.67
60 Days Ago-0.56-0.59-2.94-2.36
90 Days Ago-0.56-0.59-2.87-2.43
EPS RevisionsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstALNYIndustrySectorS&P 500
Current Qtr.-31.30%N/A-76.10%13.70%
Next Qtr.-27.50%N/A-65.30%23.90%
This Year-244.10%N/A46.40%7.70%
Next Year45.10%N/A34.90%13.00%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)-6.60%21.87%16.16%10.15%
Price/Earnings (avg. for comparison categories)-15.516.676.2729.09
PEG Ratio (avg. for comparison categories)2.3533.248.682.41
Currency in USD.